Developer docs
API playgroundTry for free, no card

Search company profiles

Neoplants

Full company profile

uuid0000uau

Namestring
Neoplants
Legal namestring
Neoplants Inc.
Websiteurl
neoplants.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Neoplants is a Paris-based biotechnology company founded in 2018 that engineers houseplants to absorb and break down indoor air pollutants, specifically formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene). Its core technology relies on proprietary genetic modifications developed over four years of research and is embodied in its first consumer product, the Neo P1, a living houseplant marketed as a natural alternative to mechanical air purifiers. The company is incorporated in Delaware as Neoplants Inc. and operates with a team of 11-50 employees led by co-founders Lionel Mora (CEO) and Patrick Torbey (CTO).

Neoplants sells directly to consumers through a Shopify-hosted e-commerce storefront, opening pre-orders for the Neo P1 in early 2023. The website exposes a global country selector covering most international markets, indicating a D2C distribution model rather than retail partnerships. The primary customer segment is health-conscious individual consumers seeking natural indoor air purification solutions, differentiated from filter-based purifiers by being a living, maintenance-light product with aesthetic value.

The company's revenue model centers on hardware sales of genetically modified plants, with pricing not publicly disclosed. In October 2022, Neoplants raised $20 million led by Heartcore Capital (with Collaborative Fund, Entrepreneurs First, Exfi, Partech, and True Ventures) to expand the technology platform into additional plant species and carbon capture applications. The company's current commercial website messaging ("A new chapter is taking root. Stay tuned") suggests the consumer product line may be in transition, with future revenue potentially diversifying into B2B climate applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioengineered houseplants, indoor air purification, plant biotechnology, air pollution remediation, genetic plant engineering
Industry1 code
PRIMARYCRAJAOAI
Eco-Friendly Air Care & Odor Control
Product category
Biotech Indoor Air Purification Plants
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Genetically Modified Plant Sales
TypeHardware Sales
Description

Primary revenue stream from selling genetically modified houseplants (Neo P1) directly to consumers. The product was offered via pre-order in early 2023 after four years of research and development. Future revenue may expand to additional plant varieties and carbon capture applications.

techcrunch.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Neo P1
Description

Genetically modified houseplant designed to absorb air pollutants such as formaldehyde and BTEX compounds. The company's first consumer product.

techcrunch.com
Core offering1 text field

Neoplants engineers genetically modified houseplants that absorb and break down indoor air pollutants, including formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene). The company sells these living air-purifying plants directly to consumers via its Shopify-powered e-commerce storefront, with the Neo P1 as its flagship product developed over four years of dedicated biotechnology research and development.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Absorbs formaldehyde and BTEX compounds from indoor air
Product overview1 text field

Neoplants is a biotechnology company specializing in plant engineering for environmental applications. Their product portfolio centers on the Neo P1, a genetically modified houseplant designed to absorb air pollutants including formaldehyde and BTEX compounds. The company is working to expand this technology to other plant varieties and applications such as carbon capture.

Product and service1 record
1Neo P1
CategoryBiotech Consumer Products / Indoor Air Purification
Description

The Neo P1 is a genetically modified houseplant engineered to absorb and remove formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene) from indoor air. It was developed after four years of dedicated biotechnology R&D and represents Neoplants' first commercial product, designed for individual consumers seeking natural, low-maintenance indoor air quality solutions.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeOthers
Description

Pivot Bio applies synthetic biology to crop microbes for nitrogen fixation — comparable biotech DNA and engineering-of-living-organisms thesis to Neoplants, but deployed in agriculture rather than consumer household products.

TypeEmerging player
Description

Awair is a smaller US indoor air quality monitoring and remediation startup focused on chemical sensitivity consumers, comparable target persona to Neoplants but with a sensing/filter combination rather than bioengineered plants.

TypeEmerging player
Description

Airthings makes consumer indoor air quality monitors (radon, VOCs, CO2) and is extending into remediation — same end use case of indoor air awareness but with sensing rather than active purification.

4IQAir
TypeBroad incumbent
Description

IQAir is a premium air purifier brand specializing in HEPA and HyperHEPA filtration for residential and medical-grade indoor environments, addressing the same formaldehyde/VOC concerns as Neoplants with established clinical positioning.

TypeBroad incumbent
Description

Dyson is a global broad-line appliance and air purifier incumbent with Purifier Cool/Heater lines, competing for the same indoor air quality wallet but with a much wider product portfolio and far larger R&D and marketing budget.

6Rabbit Air
TypeEmerging player
Description

Rabbit Air is a smaller US premium air purifier brand focused on design-conscious consumers and specialty filters — overlapping consumer persona with Neoplants but with a mechanical HEPA-based product.

TypeBroad incumbent
Description

Blueair is a long-established premium air purifier brand acquired by Unilever, selling HEPASilent technology worldwide — comparable end use case as Neoplants but with broader distribution and retail presence.

TypeDirect peer
Description

Molekule is a direct-to-consumer air purifier company using a proprietary PECO technology to destroy indoor pollutants. It targets the same health-conscious consumer use case as Neoplants with a science-driven, premium-positioned narrative.

TypeOthers
Description

Ginkgo Bioworks is a large synthetic biology platform engineering organisms for industrial applications — same underlying biotech foundation as Neoplants but serving industrial customers, providing a useful comparable for platform valuation.

TypeBroad incumbent
Description

Coway is a leading Korean home appliance brand with a sizable air purifier line (Icon, Airmega), competing in the same indoor air quality category with strong APAC distribution and lease/subscription models.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Neoplants

Biotech Indoor Air Purification Plantsneoplants.com

What Neoplants does

Neoplants is a Paris-based biotechnology company founded in 2018 that engineers houseplants to absorb and break down indoor air pollutants, specifically formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene). Its core technology relies on proprietary genetic modifications developed over four years of research and is embodied in its first consumer product, the Neo P1, a living houseplant marketed as a natural alternative to mechanical air purifiers. The company is incorporated in Delaware as Neoplants Inc. and operates with a team of 11-50 employees led by co-founders Lionel Mora (CEO) and Patrick Torbey (CTO).

Neoplants sells directly to consumers through a Shopify-hosted e-commerce storefront, opening pre-orders for the Neo P1 in early 2023. The website exposes a global country selector covering most international markets, indicating a D2C distribution model rather than retail partnerships. The primary customer segment is health-conscious individual consumers seeking natural indoor air purification solutions, differentiated from filter-based purifiers by being a living, maintenance-light product with aesthetic value.

The company's revenue model centers on hardware sales of genetically modified plants, with pricing not publicly disclosed. In October 2022, Neoplants raised $20 million led by Heartcore Capital (with Collaborative Fund, Entrepreneurs First, Exfi, Partech, and True Ventures) to expand the technology platform into additional plant species and carbon capture applications. The company's current commercial website messaging ("A new chapter is taking root. Stay tuned") suggests the consumer product line may be in transition, with future revenue potentially diversifying into B2B climate applications.

Neoplants firmographics

Firmographics
Name
Neoplants
Legal name
Neoplants Inc.
Website
https://neoplants.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Neoplants industry classification

Industry
Product category
Biotech Indoor Air Purification Plants
akta.pro industry
PRIMARYCRAJAOAI
Eco-Friendly Air Care & Odor Control

Keywords

  • Bioengineered houseplants
  • Indoor air purification
  • Plant biotechnology
  • Air pollution remediation
  • Genetic plant engineering

Where Neoplants is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Neoplants business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

  1. Genetically Modified Plant Sales: Primary revenue stream from selling genetically modified houseplants (Neo P1) directly to consumers. The product was offered via pre-order in early 2023 after four years of research and development. Future revenue may expand to additional plant varieties and carbon capture applications.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Neoplants product offering

Product offering

Core offering

Neoplants engineers genetically modified houseplants that absorb and break down indoor air pollutants, including formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene). The company sells these living air-purifying plants directly to consumers via its Shopify-powered e-commerce storefront, with the Neo P1 as its flagship product developed over four years of dedicated biotechnology research and development.

Product overview

Neoplants is a biotechnology company specializing in plant engineering for environmental applications. Their product portfolio centers on the Neo P1, a genetically modified houseplant designed to absorb air pollutants including formaldehyde and BTEX compounds. The company is working to expand this technology to other plant varieties and applications such as carbon capture.

Differentiator

Problem solved

Functional benefit

Brands

  • Neo P1: Genetically modified houseplant designed to absorb air pollutants such as formaldehyde and BTEX compounds. The company's first consumer product.

Products and services

  • Neo P1 The Neo P1 is a genetically modified houseplant engineered to absorb and remove formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene) from indoor air. It was developed after four years of dedicated biotechnology R&D and represents Neoplants' first commercial product, designed for individual consumers seeking natural, low-maintenance indoor air quality solutions.

Quantifiable outcome

  • Absorbs formaldehyde and BTEX compounds from indoor air

Companies that use Neoplants

Customer profile

Segments1 record

Ideal customer profiles1 record

Neoplants technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Neoplants partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Neoplants competitors and assessment

Company assessment

Others

  • Pivot Bio: Pivot Bio applies synthetic biology to crop microbes for nitrogen fixation — comparable biotech DNA and engineering-of-living-organisms thesis to Neoplants, but deployed in agriculture rather than consumer household products.
  • Ginkgo Bioworks: Ginkgo Bioworks is a large synthetic biology platform engineering organisms for industrial applications — same underlying biotech foundation as Neoplants but serving industrial customers, providing a useful comparable for platform valuation.

Emerging players

  • Awair: Awair is a smaller US indoor air quality monitoring and remediation startup focused on chemical sensitivity consumers, comparable target persona to Neoplants but with a sensing/filter combination rather than bioengineered plants.
  • Airthings: Airthings makes consumer indoor air quality monitors (radon, VOCs, CO2) and is extending into remediation — same end use case of indoor air awareness but with sensing rather than active purification.
  • Rabbit Air: Rabbit Air is a smaller US premium air purifier brand focused on design-conscious consumers and specialty filters — overlapping consumer persona with Neoplants but with a mechanical HEPA-based product.

Broad incumbents

  • IQAir: IQAir is a premium air purifier brand specializing in HEPA and HyperHEPA filtration for residential and medical-grade indoor environments, addressing the same formaldehyde/VOC concerns as Neoplants with established clinical positioning.
  • Dyson: Dyson is a global broad-line appliance and air purifier incumbent with Purifier Cool/Heater lines, competing for the same indoor air quality wallet but with a much wider product portfolio and far larger R&D and marketing budget.
  • Blueair: Blueair is a long-established premium air purifier brand acquired by Unilever, selling HEPASilent technology worldwide — comparable end use case as Neoplants but with broader distribution and retail presence.
  • Coway: Coway is a leading Korean home appliance brand with a sizable air purifier line (Icon, Airmega), competing in the same indoor air quality category with strong APAC distribution and lease/subscription models.

Direct peers

  • Molekule: Molekule is a direct-to-consumer air purifier company using a proprietary PECO technology to destroy indoor pollutants. It targets the same health-conscious consumer use case as Neoplants with a science-driven, premium-positioned narrative.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Neoplants social profiles

Digital presence

Neoplants financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Neoplants leadership team

Management profile

Number of profiles

Profiles2 records

Neoplants funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Neoplants M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neoplants

What does Neoplants do?

Neoplants engineers genetically modified houseplants that absorb and break down indoor air pollutants, including formaldehyde and BTEX compounds (benzene, toluene, ethylbenzene, and xylene). The company sells these living air-purifying plants directly to consumers via its Shopify-powered e-commerce storefront, with the Neo P1 as its flagship product developed over four years of dedicated biotechnology research and development.

Is Neoplants a public or private company?

Neoplants is a private company. It is classified as venture growth investor backed and is currently operating.

When was Neoplants founded?

Neoplants was founded in 2018. It employs 11 to 50 people.

Where is Neoplants based?

Neoplants is headquartered in Paris, France, in the Europe region.

How does Neoplants make money?

One revenue line is on record: genetically Modified Plant Sales.

Who are Neoplants's main competitors?

Others on record are Pivot Bio and Ginkgo Bioworks. Emerging players are Awair, Airthings and Rabbit Air. Broad incumbents are IQAir, Dyson, Blueair and Coway. Molekule is listed as a direct peer.

Does Neoplants have an API?

No public API is recorded for Neoplants.

What industry is Neoplants in?

Neoplants's product category is Biotech Indoor Air Purification Plants. Its primary akta.pro industry code is CRAJAOAI, Eco-Friendly Air Care & Odor Control.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
KompasMeet Neo Px, an Ivory Betel Genetically Engineered to Fight Air PollutionNeoplants launched Neo Px, a genetically engineered pothos plant, in the US market in April 2025. The plant, enhanced with microbiome bacteria, claims to purify air 30 times more effectively than ordinary houseplants, targeting VOCs like BTEX. The company plans future genetically modified plants for CO2 capture.Business InsiderThis $119 houseplant is bioengineered to remove harmful air pollution in your home.Neoplants released Neo Px, a bioengineered marble queen pothos that removes indoor volatile organic compounds (VOCs) using engineered bacteria. The plant is 30 times more effective than average houseplants, and the $119 package includes a six-month supply of power drops. The company plans to publish data on its phytoremediation potential.Tech TimesThis Plant-Powered Purification System Can Remove Toxins From Air By Up to 30 Times the Normal RateNeoplants introduced Neo Px, a plant-powered air purification system that boosts houseplants' toxin removal by up to 30 times the normal rate. It targets volatile organic compounds like benzene, toluene, and xylene, and is priced at $119 with six months of power drops. The startup is exploring genetically modified plants for future iterations.TechCrunchNeoplants shows off its Neo P1 bio-engineered air-purifying plantAt CES 2024, Neoplants showcased its Neo P1 bio-engineered houseplants, which it claims replace 20 regular plants in air-purifying ability. The synthetic-biology plants outperform unmodified devil's vine by 20x in removing VOCs like formaldehyde and toluene. The company, founded in 2018, has raised about $20 million.HappiOf Hearth & Health: The Home Fragrance MarketUS home fragrance sales fell for the first time in a decade last year as consumers reduced time spent at home, with unit sales for air fresheners and candles declining in mass market channels, according to Circana data cited by Kline. Despite the overall downturn, premium home fragrance brands registered growth while value brands like Kōze, exclusive to Dollar General, gained traction with cost-conscious shoppers, and the market is forecast to grow approximately 2% in 2023. Key product launches across the sector include Reckitt's EPA-approved Lysol Air Sanitizer, Pura's Pura 4 smart diffuser and new car fragrance device, Procter & Gamble's Febreze Mood Collection, and Neoplants' bioengineered air-purifying plants, reflecting the industry's focus on wellness and air quality innovation.MIT Technology ReviewThe air-cleaning qualities of plants get a genetically modified boostNeoplants, a French biotech startup, announced the Neo P1, a genetically engineered pothos that metabolizes indoor air pollutants like formaldehyde and BTEX. The plant's air-cleaning capacity is about 30% from the plant itself, with the rest handled by a proprietary microbiome that requires monthly 'power drops.' The company aims to improve the plant's contribution over time.TechSpotDesigner houseplants are engineered to fight air pollutionParis-based startup Neoplants is preparing to launch Neo P1, a genetically modified golden pothos plant designed to remove volatile organic compounds from indoor air. The company has secured $20 million in seed funding and plans to sell the plants for $179 each later this year. Scientific experts remain skeptical about the real-world efficacy of houseplants for air purification compared to ventilation or mechanical filters.TechCrunchNeoplants bioengineers houseplants to use them as air purifiersFrench startup Neoplants has developed the Neo P1, a genetically modified houseplant that uses DNA-engineered enzymes and specific soil microbiomes to metabolize indoor volatile organic compounds like formaldehyde and BTEX into plant matter. The company plans to begin preorders in the first quarter of 2023 for its $179 package, which includes the plant, a specialized pot, and three months of proprietary powerdrops. Having raised $20 million from investors including True Ventures and Heartcore, Neoplants intends to expand its technology to other plant varieties and carbon capture applications.PartechNeoplantsNeoplants, a Parisian biotech startup, is developing the first bioengineered plants aimed at combating indoor air pollution. Their plants utilize gene editing techniques to capture and transform volatile organic compounds (VOCs), significantly addressing the higher levels of indoor air pollution compared to outdoor environments. The company aspires to extend its technological innovations for larger applications, including carbon capture and storage in the future.